Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EVEREST ORGANICS Gains 7%; BSE HEALTHCARE Index Up 0.8%
Wed, 11 Sep 9:56

EVEREST ORGANICS Gains 7%; BSE HEALTHCARE Index Up 0.8%Image source: DNY59/www.istockphoto.com

EVEREST ORGANICS share price has zoomed 7% and is presently trading at Rs 149.5.

Meanwhile, the BSE HEALTHCARE index is at 44,174.7 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 2.5%) and Procter & Gamble Health (up 2.4%).

SYNGENE INTERNATIONAL (down 1.2%) and ERIS LIFESCIENCES (down 1.0%) are among the top losers today.

Over the last one year, EVEREST ORGANICS has moved up from Rs 125.9 to Rs 149.5, registering a gain of Rs 23.6 (up 18.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,436.8 to 44,174.7, registering a gain of 55.3% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 134.5%), Jubilant Pharmova (up 129.2%) and GRANULES INDIA (up 121.6%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,978.9 (up 0.1%).

The top gainers among the BSE Sensex today are Asian Paints (up 0.8%) and Bajaj Finance (up 0.8%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 25,045.8 . Bajaj Auto and Dr. Reddys are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,127.1 to 81,978.9, registering a gain of 14,851.9 points (up 22.1%).

EVEREST ORGANICS Financial Update...

EVEREST ORGANICS net profit fell 18008.8% YoY to Rs -61 million for the quarter ended June 2024, compared to a profit of Rs 0 million a year ago. Net sales declined 24.0% to Rs 324 million during the period as against Rs 427 million in April-June 2023.

For the year ended March 2023, EVEREST ORGANICS reported 115.9% decrease in net profit to Rs -2 million compared to net profit of Rs 11 million during FY22. Revenue of the company fell 7.4% to Rs 1,574 million during FY23.

The current Price to earnings ratio of EVEREST ORGANICS, based on rolling 12 month earnings, stands at -20.0.


Equitymaster requests your view! Post a comment on "EVEREST ORGANICS Gains 7%; BSE HEALTHCARE Index Up 0.8%". Click here!